SK Biopharmaceuticals Co Ltd
KRX:326030

Watchlist Manager
SK Biopharmaceuticals Co Ltd Logo
SK Biopharmaceuticals Co Ltd
KRX:326030
Watchlist
Price: 102 400 KRW -1.54%
Market Cap: 8T KRW
Have any thoughts about
SK Biopharmaceuticals Co Ltd?
Write Note

SK Biopharmaceuticals Co Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SK Biopharmaceuticals Co Ltd
Total Equity Peer Comparison

Comparables:
000100
008930
128940
S
000250
C
068760

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
SK Biopharmaceuticals Co Ltd
KRX:326030
Total Equity
â‚©283.7B
CAGR 3-Years
-9%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Total Equity
â‚©2.1T
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
5%
Hanmi Science Co Ltd
KRX:008930
Total Equity
â‚©832.2B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
7%
Hanmi Pharm Co Ltd
KRX:128940
Total Equity
â‚©1.1T
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
7%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Total Equity
â‚©276.5B
CAGR 3-Years
15%
CAGR 5-Years
13%
CAGR 10-Years
11%
C
Celltrion Pharm Inc
KOSDAQ:068760
Total Equity
â‚©381B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
8%

See Also

What is SK Biopharmaceuticals Co Ltd's Total Equity?
Total Equity
283.7B KRW

Based on the financial report for Dec 31, 2023, SK Biopharmaceuticals Co Ltd's Total Equity amounts to 283.7B KRW.

What is SK Biopharmaceuticals Co Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
37%

Over the last year, the Total Equity growth was -10%. The average annual Total Equity growth rates for SK Biopharmaceuticals Co Ltd have been -9% over the past three years , 37% over the past five years .

Back to Top